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Abstract 
Background (Kenya) 
Sub-Saharan Africa (SSA) is in the midst of experiencing an unprecedented 
increase in non-communicable diseases (NCD), specifically diabetes and 
hypertension(1, 2).  This shift has required public sector health systems, 
which have historically focused on managing acute diseases, to redesign their 
services to appropriately serve chronic disease needs(3). 
 
Issue Addressed 
In order to provide a description of our efforts to bring up comprehensive 
services for NCDs in rural Kenya within this thesis, I have specifically 
selected publications which target different aspects of the healthcare system.  
This includes our efforts related to clinical training for pharmacists, screening 
for NCDs, medication supply chains, remote phone-based care services, and 
care delivery based in the community.  Prior to the implementation of the 
programs mentioned in these domains, access to these services was largely 
not available in western Kenya.  Furthermore, the publication of our research 
from this western Kenyan cohort is designed to supplant the relatively limited 
research which emanates from rural sub-Saharan Africa (4). 
 
Research Questions 
For each of these selected publications, we defined a set of primary and, in 
some cases, secondary research questions focused on identifying the 
contextualized attributes of service delivery in this setting while also 
assessing the impact.  For the first publication on training for clinical 
pharmacists, we assessed the impact of Kenyan Bachelor of Pharmacy 
interns and North American Doctor of Pharmacy interns while providing 
clinical care in an inpatient setting in Kenya.  Our primary research question 
assessed whether there was a significant difference in the number of clinical 
interventions documented by interns from the two countries. 
In the second paper, we shifted our focus to outpatient care and wanted to 
address the uptake of different strategies of screening for diabetes and 
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hypertension.  Our primary research question assessed whether there were 
any significant differences in follow-up at the public sector clinic after 
screening positive via home-based screening (community health volunteer 
provides screening at your home) versus community-based screening (a 
community wide event is established where people voluntarily show up to 
receive screening) in a rural setting. 
In the third paper, we sought to continue to improve aspects of outpatient 
care by describing our model for improving access to medications.  Our 
primary research question focused on descriptively assessing the change in 
availability of essential medications before and after implementation of this 
model. 
In the fourth paper, we described and assessed our model for providing 
intensive diabetes follow-up remotely.  Our primary research question 
focused on whether patients experienced statistically significant 
improvements in blood glucose control after participating in this service for 
six months. 
In the fifth paper, we brought together various elements of our prior 
activities to design and evaluate the community-based model of care called 
BIGPIC - Bridging Income Generation through grouP Integrated Care.  The 
primary research question for this investigation was to identify the frequency 
with which patients who screened positive for diabetes or hypertension linked 
to care.  Secondary research questions compared the linkage frequency 
observed with this model compared to a historical control, along with a 
descriptive assessment of the loss to follow up, and an assessment of 
whether this model led to statistically significant reductions in blood pressure 
after 1 year of implementation. 
 
Short Summary of the Individual Papers with Results Linking Them Together 
Within our assessment of pharmacy training, we found that the Kenyan 
pharmacy interns provided statistically significantly more clinical 
interventions per day than their North American counterparts.  This result 
highlighted the potential for Kenyan pharmacy providers to provide clinical 
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services which were largely unavailable in western Kenya prior to this 
research.  Despite the lack of the clinically focused Doctor of Pharmacy 
curriculum in Kenya, Kenyan pharmacy interns within the Bachelors in 
Pharmacy program were able to make an average of 16.7 consultations per 
day with the medical team compared to 12.0 per day for the North 
Americans.  
In the second paper we shifted our focus to the outpatient setting and were 
surprised to find that there weren’t any statistically significant differences in 
follow-up between home-based versus community-based screening for NCDs.  
This highlighted the reluctance of rural patients to travel to public sector 
facilities for care regardless of the screening method utilized.  This realization 
led us to simultaneously focus on improving the reliability of services 
available in public sector while also trying to implement solutions to facilitate 
the provision of remote services for care.  Within our efforts to improve 
medication access in paper 3, we were able to demonstrate how our 
revolving fund pharmacy model was able to improve access to medications 
from <40% to >90%.  In paper 4, we were able to implement a self-
monitored blood glucose program and demonstrate a dramatic improvement 
in the blood sugars of patients enrolled in the self-monitored blood glucose 
program with a statistically significant 31.6% absolute decline in HbA1c.  The 
culmination of these efforts and learnings is described in paper 5, where we 
implemented the BIGPIC care delivery model which resulted in a statistically 
significant improvement in linkage to care for screened patients, a retention 
in care frequency of 70.3%, and a statistically significant mean decline in the 
systolic blood pressure of 21mmHg (95% CI 13.9-28.4, P<0.01).  
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Summary of findings from the relevant publications 
Background 
Sub-Saharan Africa (SSA) is in the midst of experiencing an unprecedented 
increase in non-communicable diseases (NCD) (1, 2).  This shift has required 
public sector health systems, which have historically focused on managing 
acute diseases, to redesign their services to appropriately serve chronic 
disease needs (3). These challenges are even more pronounced for hard to 
reach rural populations which tend to be in greater need of support because 
of their lower socioeconomic status.(5) 
Despite having more than 75% of populations in low- and middle- income 
countries (LMIC) living in rural areas, the primary concentration of healthcare 
resources is in urban areas with only limited investigation in rural areas (6).  
These dynamics have led to an environment where patients in rural areas 
have limited access to NCD services despite recent evidence suggesting a 
growing burden of non-communicable diseases, specifically diabetes and 
cardiovascular disease (1, 2). 
With the focus of care and research in urban areas, many efforts to extend 
access have tried to force fit strategies for urban settings into dissimilar rural 
settings(7, 8).  This approach has yielded suboptimal results as the barriers 
to rural care access require a re-thinking of healthcare delivery to build 
contextualized models designed around the challenges these populations face 
(5). 
In response to these challenges, the Academic Model Providing Access to 
Healthcare (AMPATH) has been advancing comprehensive, contextualized 
care delivery in western Kenya.  AMPATH, started in 1989, has created one 
of the largest HIV treatment programs with over 150,000 ever enrolled HIV 
patients(9, 10).  In order to provide comprehensive care and expand beyond 
this initial focus on HIV care, AMPATH has brought together a consortium of 
North American Universities to provide interdisciplinary care.  It is within this 
backdrop that the Purdue University College of Pharmacy (PUCOP), under my 
leadership, was invited to provide on the ground support to the AMPATH 
program as illustrated in Figure 1.  This thesis will describe the various 
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implementation research initiatives undertaken by the team I work with at 
AMPATH between July 2007 and October 2016.  The structure of the Purdue 
Kenya Partnership within the AMPATH program and the chronology of these 
efforts can be seen in Figures 1 and 2.  For the purpose of this thesis, I have 
selected areas of implementation that have been built upon each other to 
assist in improving different aspects of care delivery for chronic diseases 
(primarily hypertension and diabetes) while also describing the evolution of 
my different research efforts.  In Figure 2, the chronology of the initiatives 
described in this thesis can be seen.  My early efforts, described in papers 1-
4, all build upon each other and have provided the learnings we incorporated 
into our more comprehensive BIGPIC model.  Figure 2 also describes the 
current status of the work related to each published paper in this thesis by 
listing various indicators which highlight different metrics which characterize 
the present scale of these initiatives (the scale up is not discussed within the 
thesis itself). 
These areas of emphasis within the thesis include creation of training 
programs, assessment of screening strategies for chronic diseases (diabetes 
and hypertension), development of systems to enhance medication 
availability, implementation of remote care delivery strategies, and design 
of integrated care strategies.   
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Figure 1 Structure of the Academic Model Providing Access to 
Healthcare and the Relationship to Materials Covered Within this 
Thesis 
13 
 
 
Figure 2 Chronology of AMPATH and the Activities Described Within 
This Thesis 
Training 
There has been considerable emphasis on the relative lack of healthcare 
workers available in SSA and LMIC to respond to the growing needs of the 
population(11). The pharmacy workforce is a prime example of this 
deficiency as it has been shown that the lower the World Bank Income Status 
Classification of a country, the fewer pharmacists and pharmacies that are 
present to serve the population(12). As a region, SSA currently faces the 
greatest pharmacy workforce shortage in the world with the lowest 
pharmacist to population density which is as low as 5 per 100,000 in some 
countries(12). 
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While many efforts have successfully focused on increasing the numbers of 
healthcare workers, there is an equally important need to improve the quality 
and output of the currently available providers(13). 
In order to maximize the clinical outcomes that can be achieved with these 
limited healthcare worker resources, it is vital that all members within the 
interdisciplinary healthcare team work together to appropriately task shift 
duties instead of requiring the few available physicians to independently 
provide the majority of clinical services. 
These realizations led our team of Kenyan and North American pharmacists 
to propose that a new cadre of pharmacist in LMICs that can more effectively 
respond to both the clinical needs and medication supply needs of LMIC 
populations, could ultimately improve patient outcomes.  Despite the 
availability of clinical pharmacy providers in high-income countries, this is 
largely a non-existent practice in Kenya and most of SSA where pharmacists 
typically only participate in the dispensing of product(14).  We sought to 
assess the feasibility and impact of incorporating these providers within a 
rural inpatient setting in western Kenya, a rather typical setting for East 
Africa.  Our primary research question was to determine whether North 
American Doctor of Pharmacy students and Kenyan Bachelors of Pharmacy 
students could provide similar numbers of interventions in inpatient care. 
 
Diabetes Screening and Linkage Strategies 
After our initial emphasis on training the staff needed to participate in an 
inter-disciplinary team, we sought to characterize different aspects of 
screening for NCD’s to optimize our ability to get patients to participate in 
screening and subsequently attend facilities where care could be provided.  
While there has been considerable emphasis on researching the 
characteristics of NCD screening and treatment in urban centers in SSA, 
there has only been limited investigation on these dynamics in rural centers 
which tend to have their own unique barriers to care accession(7, 8). Within 
AMPATH’s prior qualitative investigations of the various barriers to care 
linkage for hypertension in AMPATH’s western Kenyan catchment area (see 
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Figure 3), our team of AMPATH researchers have found the primary barriers 
relate to the transportation difficulties in reaching remote facilities across 
rural terrain, financial challenges with affording the costs of care, and lack of 
trust in rural facilities (15).  As seen in Figure 3, AMPATH covers a vast rural 
catchment area with numbered and labeled primary health centers facilities 
scattered across this area.  This map highlights the transportation and 
subsequent financial challenges patients face in paying the costly expenses 
to reach remote facilities.  The publications included within this thesis include 
activities conducted across western Kenya in Eldoret (Moi Teaching and 
Referral Hospital and Moi University), Webuye (Webuye SDH), Mosoriot 
(Mosoriot PRTC), Turbo (Turbo Health Centre), and Sinoko (near Sinoko 
Dispensary and Webuye SDH).   
 
Figure 3 - Map of Main AMPATH Facilities Across Western Kenya(16) 
In order to complement our qualitative analysis of barriers to linkage to care, 
we wanted to assess the quantitative linkage to care after utilizing different 
screening strategies for NCD’s as there weren’t any previous comparison 
studies looking at the differences in linkage when using home- versus 
community-based screening. Without an emphasis on studying actual patient 
behaviors related to linkage to care after screening, we knew the impact of 
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our costly screening efforts would be muted without a greater understanding 
of this crucial, understudied aspect of health care access.  This set the stage 
for one of our first investigations where we assessed the prevalence and 
linkage frequencies of NCDs when using the home and community-based 
screening strategies. 
 
Enhancement of Medication Availability within the Public Sector Supply Chain 
Systems 
As we identified the main barriers to getting patients to access health care, 
the need for sustainable systems to meet the demands of the many patients 
now seeking access to care became very clear.  With the availability of 
medications for non-communicable diseases in the public sector estimated at 
less than 36% across SSA, the many patients seeking care are often left 
without viable care options as they incur considerable extra expense 
traveling to poorly stocked facilities which are incapable of reliably 
addressing their basic health needs (17).  This is further complicated by the 
many reports highlighting the high frequency of falsified and substandard 
medications in SSA(18).  We postulated that this inadequately performing 
supply chain was one of the main culprits behind the low uptake of NCD 
services and resultant poor outcomes consistently reported throughout SSA 
for NCDs like diabetes(19).  In order to counter this, we wanted to prove that 
it is possible to create a reliable and sustainable supply chain system 
incorporating quality assured medications at affordable prices for rural 
populations in partnership with the MOH.  We also wanted to prove that 
much higher availabilities of medications could be achieved in these facilities 
which would result in greater uptake and utilization of pharmacy services.   
 
Remote Care Delivery 
As we addressed several of the healthcare system’s needs in training 
pharmacy providers and ensuring access to potentially life-saving 
commodities, we began to develop a greater awareness of the many high 
risk patients in need of much closer medical supervision.  These needs for 
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closer follow-up were especially pronounced for patients with insulin 
dependent diabetes. Unfortunately, most public sector SSA healthcare 
settings are not equipped to provide the recommended care strategies for 
chronic diseases like diabetes, as standard services such as having a basic 
point of care glucometers and glucose strips are only available at a median of 
13% of public sector facilities in countries sampled across SSA.  The poor 
availability of glucose monitoring supplies in facilities makes the prospect of 
home-based monitoring a distant consideration for the vast majority of 
patients in need of such services.  While glucometers are available for 
purchase in the private sector, the vast majority of patients, especially those 
in rural areas, do not have them incorporated as a part of their care(20, 21). 
This is further complicated by the relatively lower literacy levels which 
highlight another challenge in implementing more intensive monitoring 
strategies which require considerable patient education and understanding to 
maximize the impact(22, 23).  
We hypothesized that despite the relatively lower literacy reported for 
populations like those found in rural western Kenya, we could impart 
significant benefit from an intensive glucose monitoring program if the 
supplies and guidance were provided to participate in this modality of care.   
 
Integrated Care Delivery Strategies 
While our activities with the supply chain and more intensive management 
have improved the care patients who travel to facilities receive, it has not 
sufficiently improved the health outcomes of entire communities as desired 
as only a small percentage of patients end up seeking care.  It is because of 
these realizations that we have arrived at the main focus of this thesis- the 
Bridging Income Generation through grouP Integrated Care (BIGPIC) 
program.  Through our extensive experience in building up other components 
of the healthcare system related to training, screening, supply chain support, 
and phone based care delivery; we had a well-developed foundation of care 
delivery that we proposed could be used to extend cost-effective care 
delivery within the community.  For example, through the scale-up of the 
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Revolving Fund Pharmacy model, medications were now readily available 
throughout public sector facilities within our catchment area.  This reliable 
pharmacy infrastructure was then used to supply medications directly to 
community groups without requiring them to incur the costly expenses 
associated with traveling to facilities.  By leveraging the foundational 
infrastructure we have built, we were able to create new models of care that 
are purposefully designed to provide sustainable, replicable, and cost-
effective care in rural settings to overcome the aforementioned barriers. 
Our primary questions with our initial research efforts on this novel model 
were the following: 
1. Do linkage and retention rates to care for patients who are screen 
positive for NCDs change when you shift to this more comprehensive 
holistic approach? 
2. What kind of clinical outcomes are observed when the full complement 
of services and medications for NCD care are provided in a portable, 
microfinance group linked delivery model 
For our pilot evaluation of the BIGPIC model we focused on addressing these 
two questions to provide a foundation for future evaluation as we continue 
our efforts to scale up patient centric, holistic models of care in developing 
world settings.  This project was the culmination of my prior efforts in Kenya 
and is now the focus of my ongoing implementation efforts. (24) 
  
19 
 
Commentary linking the work done  
Project 1 – Training of staff to support the healthcare system (publication 1) 
Introduction: 
With the well documented limitations in the size of the healthcare workforce 
in SSA, one of our first priorities was to develop a model for training that 
could maximize the utility of the currently available staff.   
In our effort to develop the workforce needed to support and sustain our 
various healthcare delivery programs, our primary emphasis was on creating 
experiential education programs to train the staff needed to oversee and 
scale up many of our envisioned future activities.   
This includes a first of its kind experiential training program for students from 
the University of Nairobi (publication 1) (25), a post graduate diploma 
program in Clinical Pharmacy (publication 6) (26), and a masters in Clinical 
Pharmacy (Publication 6).  The students enrolled in these programs now form 
the core leadership for the many activities described in the subsequent 
sections. 
At the inception of these experiential education programs, we wanted to 
assess the impact of our Kenyan pharmacy interns in making clinical 
interventions in a Kenyan tertiary referral hospital.  Despite the well 
documented impact of clinical pharmacists in high-income countries (HIC), 
there is only limited data describing the potential role of SSA pharmacy 
trainees in promoting clinical services.(27)  Instead of continuing to promote 
a simple increase in the numbers of healthcare providers, our efforts have 
focused on increasing the output and impact of the already available 
healthcare resources.  In order to prove the potential impact of our efforts, 
we compared the performance of North American pharmacy interns and 
Kenyan pharmacy interns in terms of the number of interventions they made 
during inpatient rounds.   
Methods: 
This study was a retrospective, pilot study of documented consultations 
provided by all pharmacy interns and Kenyan pharmacists at MTRH from 
August 2008 to October 2008. The primary objective was to describe and 
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compare consultations provided by both North American Doctor of Pharmacy 
interns and Kenyan Bachelors of Pharmacy interns to identify differences 
between North American and Kenyan student activities and further advocate 
for expansion of clinical pharmacy services within Kenya.  This question is of 
importance as the North American model for pharmacy education has shifted 
to the more clinically oriented Doctor of Pharmacy curriculum as opposed to 
the Bachelors of Pharmacy curriculum still used in Kenya.  With only limited 
examples of clinically oriented pharmacy practice to expand the scope of 
pharmacy practice in Kenya to include more clinically oriented activities, we 
wanted to assess whether the current curriculum and resultant workforce 
would be able to document a similar level of impact in terms of the number 
of clinical interventions(12, 28).   
Descriptive statistics were used to evaluate commonly accepted consultations 
for type of consultation and pharmacotherapeutic area of consultation. 
Additionally, mean and median values were used to describe consultations 
provided by each student. The number, type, and pharmacotherapeutic area 
of commonly provided consultations were measured for Kenyan and 
American students. The intervention data were adjusted to 100 days of 
participation in patient care rounds. Parametric data were compared using 
the t test and nonparametric data were compared using the Wilcoxon rank-
sum test.  
Results: 
During the period of evaluation, we found that the North American students 
documented 12.0 consultations per day compared with 16.7 consultations 
per day documented by Kenyan interns(p<0.001).  The most common areas 
of consultation were medication reconciliation, chart review, medication 
acquisition, and drug information for physicians (Table 1). Kenyan students 
provided significantly more consultations in the areas of drug information for 
families, patients, and nurses, medication acquisition from the pharmacy, 
and in clarification of medication orders (p<0.05) as seen in the table 1 and 
2. North American students provided more consultations in the area of 
diagnostic laboratory tests (p<0.001). 
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Table 1 – Type of Consultations Provided by American and Kenyan 
Pharmacy Students during an Acute Care APPE in Kenya  
 
Table 2 – Therapeutic Category of Consultations Provided by 
American and Kenyan Pharmacy Students in an Acute Care APPE in 
Kenya 
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Summary and significance of the publication 
This study helped demonstrate several key findings that have helped support 
many of our future efforts in pharmacy education in Kenya.  The results 
highlight the potential for a more clinically focused practice for Kenyan 
pharmacists with the current Bachelors in Pharmacy training.  Furthermore, 
our results highlight the exemplary capability of Kenyan students as they 
documented significantly more interventions than their counterparts from 
North America.  This study showed that the Kenyan students consistently 
provided more interventions in the aspects of healthcare delivery that require 
interdisciplinary collaboration and communicating with members of the 
community largely owed to their greater awareness of the local infrastructure 
and cultural norms.  The North American interns showed a statistically 
significant increase in the number of interventions related to recommending 
laboratory tests which could be explained by the greater reliance on 
laboratory tests in North American settings as opposed to the greater 
reliance on clinical diagnosis in sub-Saharan Africa(29).  The findings from 
this study emphasize the importance of contextualizing approaches around 
the local environment by working with local providers to guide all activities.  
While this study was limited by the small numbers of students included 
within both arms and relatively short period of assessment, it provided the 
initial pilot data to help justify the growth of our program in numerous 
domains related to pharmacy education. 
 
Project 2 – Chronic Disease screening/linkage strategies (Publication 2) 
Introduction: 
As we continued to make considerable headway in creating effective training 
programs, we wanted to expand the reach of these highly trained individuals 
by having them address the major healthcare gaps plaguing rapidly 
developing countries like Kenya.  Despite the recent increase in concern over 
the growing burden of hypertension and diabetes mellitus, there are very few 
studies reporting the prevalence of these diseases or replicable screening 
strategies in Kenya, especially in rural areas(30, 31).  By 2025, the number 
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of adults with hypertension is predicted to increase by approximately 60% 
and almost three-quarters of the world’s hypertensive population will be in 
low and middle income countries (32). Studies have also found similar trends 
in the prevalence of diabetes, with prevalence rates ranging from < 1% in 
rural areas to > 20% urban settings with variation according to racial/ethnic 
group (33).  In order to begin tackling these growing problems, we wanted to 
focus our early efforts on better understanding the burden of disease while 
simultaneously studying the impact of two frequently utilized screening 
strategies on the health behaviors of patients.  Therefore, we conducted a 
feasibility study to compare two strategies for screening in our catchment 
area: community-based versus home-based screening(34-36).  Our primary 
aim was to provide an estimate of disease prevalence via both methods 
which could then be used to inform local public health policy and health 
system planning.  We also assessed the likelihood of returning for care at a 
facility after being identified as screen positive via the two screening 
strategies.   
 
Methods: 
Within this pilot investigation, we sought to identify the prevalence of 
diabetes and hypertension by utilizing the two commonly utilized screening 
strategies in similar settings.  Within the community-based screening arm, 
we organized village based health fairs to provide education and point of care 
glucose and blood pressure testing to all interested members of the 
community.  Within the home-based screening arm, we utilized AMPATH’s 
network of counselors to go door to door to screen people using the same 
point of care testing done in the community screening arm.  All patients who 
screened positive were instructed to return to the facility for confirmation. 
All participants with complete data recorded in the screening register were 
included within this analysis.  Descriptive analyses were used to characterize 
the demographic characteristics of the findings of the two different screening 
strategies. In both analyses, the percentage of participants with an initial 
positive screening was calculated. The Fischer’s Exact Test was utilized to 
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compare the difference in the likelihood of screening positive for diabetes or 
hypertension in the home-based versus community-based screening 
strategy.  Additionally, the likelihood of following up after a positive 
screening test was compared between the two screening strategies and odds 
ratios (OR) for a positive screening were calculated.  Linear regression was 
performed to determine the characteristics associated with a positive 
screening for both diabetes and hypertension.  All analyses were completed 
using STATA® (College Station, Texas, Version 8). 
Results: 
There were 236 participants in the home-based screening versus 346 
participants in the community-based screening who met the inclusion criteria 
for this analysis with participants having a mean age of 37 (SD=15) and 39 
(SD=13) years, respectively.  The home-based screening strategy identified 
13 participants (6% of the total population screened) with a SBP greater than 
or equal to 160mmHg compared to the community-based strategy which 
identified 35 participants (10% of the total population screened) as seen in 
Figure 4.  Participants in the community-based screening were almost twice 
as likely to have a positive screening for hypertension compared to the 
home-based screening arm, however, this result was not statistically 
significant (OR=1.93, Fischer’s exact test, P=0.06).  With regards to diabetes 
screening, 54 participants (23%) and 27 participants (8%) in the home-
based screening and community-based screening, respectively, met the 
predefined threshold requiring confirmatory blood sugar testing.  Participants 
in the home-based screening were statistically significantly more likely to 
have a positive screening result than the participants in the community-
based screening (OR=3.51, Fischer’s exact test, P<0.01). 
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Figure 4 - Flow Chart for Screening Results in Home- and 
Community-based Screening 
Follow-up rates 
The primary finding of interest was the surprisingly low rate of follow-up for 
confirmatory testing in clinic for both screening strategies.  Of the 13 
participants (6%) in the home-based screening arm with a SBP ≥160mmHg, 
4 (31%) returned for confirmation as seen in Figure 4.  All 4 of these 
participants had a SBP ≥ 140mmHg when confirmatory testing was done.  
Similarly, in the community-based screening, 11(31%) of the 35 participants 
identified with an SBP ≥ 160mmHg returned for confirmation and all of these 
participants were confirmed to have a SBP ≥ 140mmHg.  There were only 
negligible differences in the odds of returning for confirmatory follow up 
between the two groups (OR=0.97, Fischer’s exact test, P=1.00) 
In the analysis of blood sugar screening, 12(23%) of the 54 participants 
meeting the predefined criteria for referral returned for the confirmatory 
fasting blood sugar in the home-based screening with 3 receiving a 
confirmed diagnosis of diabetes mellitus.  In the community-based arm, 
6(22%) of the 27 participants returned for the confirmatory fasting blood 
sugar with only 2 participants being confirmatively diagnosed with diabetes.  
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There were only negligible differences in the odds of returning for 
confirmatory follow up between the two groups (OR=1, Fischer’s exact test, 
P=1.00) 
None of the participants in the home-based screening that had elevated 
blood pressures or blood sugars tested positive for HIV. 
 
Summary and significance of the publication: 
Prior to the completion of this study, we assumed that a more convenient 
and individualized home-based screening approach would lead to 
considerably higher rates of subsequent follow-up by patients at stationary 
facilities.  While much of the research supporting these assumptions came 
from the focused investigation on HIV in SSA settings (37-42), we were 
surprised to find that the screening modality had no impact on the follow-up 
rates for NCDs.  Furthermore, we were surprised by the unexpectedly low 
follow-up rates in all the subgroups as we did not anticipate such low rates of 
linkage to the public sector facilities in that region as they have a reputation 
for providing high quality services relative to other government facilities in 
Kenya(43).  The findings from this study heavily influenced our future efforts 
as it highlighted the aversion rural patients show to seeking care at 
stationary facilities. 
 
Project 3 Supply Chain - Revolving Fund Pharmacy  
Introduction: 
As we continued to better understand the burden of NCDs in settings where 
the primary healthcare focus had primarily been on infectious diseases, the 
limitations in addressing the multitude of other disease states patients in this 
setting face became clearly apparent.  One of the major gaping holes was 
within maintaining a responsive supply chain.  While medications for 
traditionally donor supported infectious diseases like tuberculosis and HIV 
were typically always available, the lack of funding for NCDs has forced rural 
patients to rely on public sector supply chain systems.  Unfortunately, the 
lack of funding has resulted in dismal availability throughout sub-Saharan 
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Africa as reports have found NCD medication availability of approximately 
36%(17).  As we continued to build systems for managing diabetes and 
hypertension, the suboptimal supply chain became the primary rate limiting 
step for all of our expansion plans.  To combat this, we wanted to build a 
donor seeded, but patient sustained model that worked in conjunction with 
the Ministry of health (MOH) instead of in isolation.  To meet this 
requirement of being donor seeded, we established the Revolving Fund 
Pharmacy (RFP) which was designed to sustainably improve the 
responsiveness of the MOH supply chain.  The model operates under the 
guiding principles seen in Table 3. 
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Table 3 – Guiding Principles to Govern the Revolving Fund Pharmacy  
Methods: 
In order to effectively characterize the design of the RFP for other 
implementers in LMIC’s and provide a description of the utilization patterns, 
we completed a service evaluation to describe the impact of this model on 
the availability and purchase of medications. 
Between one to three months prior to the implementation of RFPs through 
this project, a cross sectional availability assessment of 75 essential 
medications that the Kenyan MOH is responsible for supplying to facilities 
was performed at potential implementation sites.  This evaluation was 
performed to generate a rough estimation of the needs of the potential 
implementation site facilities and to project the quantities of different 
medications needed to provide comprehensive care beyond HIV.  After the 
implementation of the RFP model, the RFP staff in each facility maintained a 
daily list tracking the availability of essential medications.  Auditors would 
then check these lists and perform a direct stock take to validate the findings 
and confirm the availabilities of medications.  The percentage availability was 
then calculated by dividing the number of medications available by the total 
number of medications that are supposed to be stocked at each facility.  
 
Results: 
During the period of evaluation, three pilot RFP sites were started with formal 
agreements established with the management of the overarching facilities. 
For the selected sites, the initial cross sectional availability prior to RFP 
implementation for the 75 essential medications was 40% in Mosoriot health 
centre while Turbo health centre was 36%. Moi Teaching Referral Hospital in 
Eldoret houses an outpatient HIV clinic that previously only stocked non-HIV 
medications when they were donated, so their availability was sporadic and 
typically less than 10% (44). 
Within each of the RFPs, the number of patient encounters had rapidly grown 
over the period of assessment as seen in Figure 3. In the first quarter of 
operations, the lowest volume RFP had an average number of 89 patient 
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encounters each week.  However, by the fourth quarter of evaluation, the 
RFPs each had an average of over 200 patient encounters per week. During 
one year of evaluation, the three sites had a combined total of 33,714 
patient encounters.  Since many patients typically receive a prescription for 
more than one drug, the number of medications supplied is far more than 
this total, with the same patients likely returning for refills.  As of February 
2014, the first 3 RFPs have had a total of 115,991 patient encounters, with 
an average of 21%, 25% and 39% of total sales being attributable to chronic 
disease medicines in the Mosoriot Health Centre, Turbo Health Centre and 
Eldoret HIV clinic RFPs respectively.   
In February 2014, nearly three years after starting the first RFP, a cross 
sectional analysis revealed that Mosoriot Health Centre’s availability was 
90%, Turbo Health Centre’s was 94%, and the Eldoret HIV clinic’s was 91%.  
All three facilities have demonstrated sustainable operations after 1 year of 
implementation and have only had to provide a waiver for services for less 
than 2% of patients served.   
 
Figure 5 - Utilization Patterns for Three Sites of Evaluation 
Summary and significance of the publication 
The key finding from this paper was that the willingness to pay and demand 
for NCD medications was much higher than previously expected.  Once 
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again, the literature surrounding HIV care has led us to assume that patients 
in these settings are unable to afford any user fees.  Prior studies assessing 
HIV care found dramatic reductions in utilization of HIV services before and 
after the introduction of user fees(45).  Within our RFP model, we were able 
to demonstrate consistent growth in utilization and had only 2% of the 
population receive waivers for medications due to an inability to pay.  We 
were also able to demonstrate that many of the previously identified barriers 
within the MOH supply chain could be overcome by following a basic set of 
guiding principles designed to ensure sustainability, accountability, and 
affordability.  The early demonstration of success with this model has now 
led to the expansion and creation of over 50 RFP’s throughout western Kenya 
with plans underway to make our RFP model the primary model utilized by 
the MOH.  All RFPs are still in operation and continue to enjoy an outpouring 
of support from the communities and facilities where they operate.  This 
model has also facilitated the creation of an insurance product that includes 
access to the RFP as one of the primary benefits.  In addition, the ability of 
the RFP to include non MOH supported medications within the formulary has 
also played a vital role in the expansion of many new care programs being 
introduced by AMPATH including services for maternal and child health, 
cardiovascular disease/venous thromboembolism, malignancies, and 
pediatrics. 
 
Project 4 Remote Care Delivery (publication 4) 
Introduction:  
As we made improvements to medication access in public sector facilities and 
improved our understanding of patient behaviors with different screening 
strategies, we started to shift our focus to addressing the needs of patients 
requiring more intensive follow-up.  Patients with insulin dependent diabetes 
serve as a prime example of this type of patient population as they require a 
basic level of facility based care combined with extensive self-care.  The 
limitations in healthcare infrastructure in certain areas in SSA has created a 
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harrowing situation for most patients with insulin dependent diabetes as 
most are not expected to survive more than a year (46). 
Despite practicing within one of Kenya’s two tertiary referral centers, similar 
trends with poor care for patients requiring insulin were seen.  The initial 
glycosylated hemoglobin (HbA1c) data from MTRH revealed that the average 
HbA1c was 10.4% (DCCT units) with patients requiring insulin being 
responsible for 63% of the HbA1c values above 14%(47). 
This combination of realizations led us to establish a home-based self-
monitored blood glucose (SMBG) program to provide intensive monitoring to 
patients with diabetes who were at high risk for complications.  Our primary 
research question was to determine whether this care modality could lead to 
statistically significant reductions in blood glucose control after 6 months of 
enrollment. 
Methods: 
Within this program, patients were provided with counseling and a point of 
care glucometer to check their blood sugar twice a day from the comfort of 
their home and receive a weekly call where they would relay their results to 
specially trained providers and receive advice on dosage adjustments as 
outlined in a stepwise fashion in Figure 6. 
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Figure 6 - Steps in Enrolling and Following up with Patients for the 
Self-Monitored Blood Glucose Program 
During their routine in-person clinic visits, patients had A1C tests at 3- to 6-
month intervals using the POC DCA Analyzer (Siemens, Erlangen, Germany). 
Whenever patients were registered to receive general diabetes care, diabetes 
staff and peer educators administered a comprehensive initial assessment 
form that captured a wide variety of demographic and personal 
characteristics. 
The primary analysis was to demonstrate the impact of this approach in 
changing the median HbA1C from baseline to 6 months after enrollment. 
Because of the variability and unpredictability of patient follow-up visits, the 
date of the HbA1C was rounded up or down to the closest 3-month interval 
for the purpose of analysis.  All patients included in this investigation had an 
evaluable result for the primary outcome measure.  For all other HbA1C 
analyses, the HbA1C was recorded under the closest 3-month period from 
the date of enrollment.  The Wilcoxon sign rank test was used to compare 
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baseline and 6-month HbA1C results and a P value <0.05 was considered 
statistically significant. 
In addition to the primary outcome, the trends in SMBG changes from 
baseline were tracked and compared using the paired Student’s t test. SMBG 
results from the first week, after testing supplies were received but before 
phone calls were initiated, were considered to be the baseline results. For 
patients who had prolonged enrollment beyond 6 months, SMBG results were 
analyzed descriptively to assess trends in results over an extended period of 
time and compared to the original baseline values to determine whether 
statistically significant differences in glucose control persisted. To identify 
potential trends in sub-populations within the program, univariate Wilcoxon 
rank sum analyses were performed to compare the change in A1C at 6 
months against the demographic and personal characteristics collected 
during enrollment. Any characteristic showing a P value <0.2 was then 
introduced into an adjusted multivariate linear regression model to provide 
adjusted 95% confidence intervals for the percentage change in A1C from 
baseline to 6 months. 
 
Results: 
A total of 139 patients met the eligibility criteria and were included in the 
study. Two of these patients were later lost to follow up and excluded from 
the analysis because they did not have the required A1C test at 6 months. 
Analysis of the primary outcome across the full cohort (n = 137), found a 
statistically significant 4 point difference (P<0.01), between the median 
baseline (13.3%) and 6-month A1C results (9.3%) (31.6% absolute 
difference between the median baseline and 6-month A1C results). For 
patients who were followed beyond 6 months, a statistically significant 
decline (P <0.01) was maintained compared to baseline at each subsequent 
3-month period of evaluation. Similarly, the SMBG program yielded 
statistically significant declines at each 3-month interval compared to 
baseline as seen in Figure 7. 
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Figure 7 - Trends in Glycemic Control Amongst Self-Monitored Blood 
Glucose Participants 
In the secondary analysis of factors that might be associated with response 
to this intervention, patients diagnosed with diabetes before the age of 25 
years were statistically significantly more likely to have a lower percentage 
change in A1C after 6 months than the rest of the population, in both 
unadjusted and adjusted analyses (Table 4).  A trend toward worse control 
among pediatric patients <15 years of age was also seen, but this was not 
statistically significant. Patients who were enrolled in the general diabetes 
care program for <5 years had a statistically significantly lower percentage 
improvement in A1C in both the adjusted (P <0.03) and unadjusted (P 
<0.001) analyses. Patients who received care in the rural clinic experienced a 
greater reduction in A1C than those who received care at the more urban 
MTRH clinic (P <0.01 in both adjusted and unadjusted analyses). 
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Table 4 - Association of Risk Factors with Response to Self-Monitored 
Blood Glucose Intervention 
Summary and significance of the publication 
Patients in this setting receiving this previously unavailable care modality, 
showed a rapid and dramatic improvement in glycemic control.  Prior to the 
implementation of this intervention, there was only one other published 
account of the impact of home glucose monitoring in SSA which came from 
South Africa(48).  Our published account represents the largest published 
cohort describing the experience with home glucose monitoring and provided 
our team of investigators with considerable insight into the immense 
potential with self-care amongst populations which were thought to be 
incapable because of the low levels of literacy typically found in these 
settings (49).  The capability of different types of patients with diabetes to 
benefit from this care modality was further supported by the statistically 
significant improvement in HbA1c amongst rural patients compared to the 
semi-urban population.   
The findings from this study are consistent with the findings from one of the 
only other assessments of home blood glucose monitoring conducted in SSA  
in Soweto, South Africa which also showed a statistically significant decline in 
HbA1c(48).  Despite the limited data available on this care modality in SSA, 
both studies have shown benefits similar to the well described benefits in 
high income countries where this care modality is a standard part of care.  
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Efforts should be undertaken to expand access to this service and further 
document the impact on care in much larger cohorts. 
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Project 5 – Integrated Care Delivery (Publication 5) 
Introduction: 
While all of the aforementioned projects reflect the implementation of 
contextualized stationary facility based healthcare delivery, they fail to 
address the large majority of patients who are unwilling to travel to receive 
care at public sector facilities.  These prior models also only focused on the 
traditional aspects of healthcare instead of considering the broader 
determinants which heavily influence care seeking behavior especially 
amongst rural populations(15, 50).  After years of studying all the 
aforementioned aspects of health care delivery in rural western Kenya 
described in this thesis, I designed the Bridging Income Generation through 
grouP Integrated Care (BIGPIC) model with my team of colleagues. 
In western Kenya and throughout SSA, low linkage and retention to care 
contribute to the inadequate control of NCDs in rural settings (9, 12, 19, 20, 
22, 51-53). In Kenya, over 50% of the population earns less than $1 per 
day, and user fees for rural outpatient NCD care have been shown to 
adversely affect access to care (54) (15). With 75% of the population living 
in rural areas and experiencing these economic realities in SSA, 
contextualized solutions for addressing the barriers to care for underserved 
rural populations must be found (6).  
The BIGPIC model addresses these challenges by utilizing a stepwise care 
delivery model that is designed to address the unique barriers faced in rural 
settings.  This model emphasizes the following steps: 1-Find patients 
portably, 2- Link to peer/microfinance groups, 3-Integrate education, 4-Treat 
portably, 5-Enhance economic sustainability, and 6 – Generate demand for 
care through incentives as seen in Figure 8 and explained within the methods 
section.   
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Figure 8 – BIGPIC Model of Care 
Methods: 
We implemented the pilot BIGPIC initiative in a rural area called Sinoko, 
which has an estimated population of 21,207 people, covers an area of 30.2 
km, and is approximately 7 km from the nearest paved road.  We screened 
individuals residing within a 3 km radius of a MOH supported dispensary(10, 
55).  Farming is the main economic activity for residents in this area. 
The screening was conducted between November 2012 and April 2013 with 
different locations within Sinoko being targeted.  Individuals who showed up 
for the screening were included within the data analysis for this evaluation.  
The only participants who were excluded from this study were those that 
refused to participate in any of the healthcare screening activities.  All other 
participants were included within this evaluation. 
Description of Intervention 
BIGPIC utilizes an approach that is designed to combine six different pillars 
of service delivery into a single comprehensive system focused on 
sustainably delivering healthcare services as illustrated in Figure 8 and 
described below.   
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Pillar 1 - Find Patients Portably  
Community health workers (CHW) received stipends from the program to 
make the community aware of the upcoming NCD screening and wealth 
generation activity that was planned through the implementation of the 
BIGPIC program by informing village elders and chiefs, distributing fliers, and 
making announcements at community gatherings.  The BIGPIC activities 
were conducted through portable service delivery within the community and 
involved both microfinance experts and NCD trained staff.  The NCD trained 
staff performed point of care screening using an automatic 
sphygmomanometer cuff to screen for hypertension and a portable point of 
care blood glucose meter to screen for diabetes.  Patients who were 
confirmed to be screen positive were informed by local CHWs of the need for 
future follow-up that could be received by attending group meetings.  
Pillar 2 - Link to Peer / Microfinance Groups 
The CHWs informed all the positively screened patients of the date, time and 
location of the initial education session where all the detailed aspects of the 
intervention were explained with a special emphasis on microfinance.  CHWs 
would communicate information to these individuals primarily by meeting 
them at routinely held local meetings or by visiting their houses as they 
typically reside within the community they serve.  Participants were also 
contacted by phone if these other methods were not adequate.  All 
participants then received guidance on forming self-selected peer 
microfinance groups of 10-30 members which included patients who were 
confirmed to have hypertension and/or diabetes along with members of the 
community who wanted access to microfinance services.  The members of 
the microfinance group would decide on a meeting point for these 
microfinance meetings amongst themselves.  Typical meeting points included 
houses of members, churches, and schools. 
Pillar 3 - Integrate Education 
In addition to receiving training on establishing microfinance groups, 
participants received health education on appropriate management of their 
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condition, ways to improve agricultural output, and the importance of saving 
money to prepare for future life events.   
Pillar 4 - Treat Portably 
After receiving basic health education including information on the ministry of 
health standard charges to be expected for portable health care services, the 
groups were visited on a monthly basis by trained healthcare providers 
during their microfinance meetings.  These providers brought point of care 
laboratory tests, medications and provided consultations to all patients 
wanting to access care.  Examples of charges patients paid for services 
include ~$1.00 USD for consultation with a clinician, ~$1.00 USD per point 
of care glucose test, and ~$0.01 USD per hydrochlorothiazide 50mg tablet.    
Pillar 5 - Enhance Economic Sustainability  
The economic component of the project was focused on establishing Village 
Savings and Loan Associations (VSLA) microfinance associations that were 
designed to assist communities with mobilizing and managing their own 
savings, providing interest-bearing loans to members without a requirement 
for collateral. While the core members of the group were all patients with 
hypertension and/or diabetes, additional members, regardless of health 
status, were allowed to join the groups up to a maximum of 30 members per 
group.  Through the VSLAs, patients were able to access affordable loans and 
get business advice from program officers who were also responsible for 
ensuring groups accurately monitored and reported all financial transactions.  
At the end of each year, all members received a proportionate share of the 
savings and interest accumulated over the course of the year with their 
proportion being determined by their relative contribution to savings.  The 
savings and interest generated from this activity were described 
descriptively.  
Pillar 6 - Generate Demand for Care through Incentives 
During the initial education sessions, the groups received instructions on the 
incentives that could be earned through the management of their health 
condition.  Incentives were awarded at two levels of participation – the group 
level whereby the top three groups with the most improved process and 
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outcome metrics received rewards in the form of additional capital for the 
microfinance group, and at the individual level whereby each participant 
attaining pre-set goals received a reward, regardless of whether their group 
won or not.  Within these scoring criteria, each patient was evaluated on 
their performance on basic process metrics including attendance at regularly 
scheduled clinic visits, purchase of medication refills, and payment for a 
recommended lab or radiological test.  Clinical outcomes were also 
evaluated, however, these received much lower weighting in the overall 
score than the aforementioned process metrics.  Any individuals scoring 
higher than 80% in this scoring criterion received a cash prize of ~$5; those 
meeting 100% receiving ~$10 and a cell phone valued at ~$15.  For the 
group prizes, the group coming in first place received ~$10 per group 
member, second place received ~$7.50 per group member, and third place 
received ~$5 per group member. These incentive payments were paid from 
the revenue generated from care delivery and then paid out to members 
during the microfinance activities.  The remaining revenue generated from 
payments for care was used to screen new patients and initiate the model in 
additional sites. 
Analysis 
The progression of participants through the five different phases of BIGPIC 
are illustrated in Figure 9: Phase 1-Initial Screening, Phase 2-Confirmation of 
Disease by Repeat Testing on the Same Day, Phase 3-Linked to Care by 
Attending Initial Care Education Session, Phase 4-Patients Joining Groups, 
and Phase 5-Patients Remaining in Care after 9 Months of Group Care.  
Descriptive statistics were used to describe the primary outcome of linkage 
frequencies amongst patients who screened positive for either diabetes or 
hypertension.  A positive linkage event was defined as having an individual 
who screened positive for hypertension and/or diabetes and then returned to 
a subsequent group meeting.  An overall linkage frequency to return for care 
was calculated by dividing the number of screen positive individuals with a 
positive linkage event by the total number of screen positive individuals.  In 
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addition, the linkage frequency amongst four different possible categories: 
hypertension only, diabetes and hypertension, diabetes only, or previously 
known history of diabetes and/or hypertension on treatment was also 
calculated.  The linkage frequency of men versus women was also calculated 
using the chi-square test. In order to compare linkage frequencies with the 
BIGPIC approach relative to the more traditional model of healthcare 
delivery, the Fischer’s exact test was utilized to compare the likelihood of 
linking to care in the current strategy compared to the previously published 
historical comparison group(51).  In the historical group, a similar 
community-based screening strategy was utilized to identify individuals with 
hypertension and/or diabetes within an area that is located in the same 
county approximately 10 km away from the location studied within this pilot 
study.  In the historical control, all screen positive patients were instructed to 
return to a stationary ministry of health facility for confirmation and 
subsequent care as opposed to the community-based model utilized within 
the current pilot.  In both models, patients were informed of pre-specified 
days where confirmation testing would be available for free in the 1-month 
period following the screening.  The same definition for a linkage event was 
used in both studies.  In addition to the Fischer’s exact test, a regression 
analysis controlling for known potential confounders such as age and gender 
was also performed.  
For the secondary measure assessing clinical outcomes related to blood 
pressure, the paired t test was used to compare the baseline SBP and DBP 
results with the results obtained after 12 months from the initial screening 
activity.  The mean blood pressure results were also calculated at 3 month 
intervals and compared to the baseline result.  In addition to this clinical 
outcome, the percentage of patients retained within care was calculated by 
assessing the number of patients who remained in care (Phase 5) after 
joining the group care model (Phase 3).  For diabetes-related measurements, 
descriptive statistics were used as there was an insufficient sample size to 
perform meaningful statistical analysis. 
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All statistical analyses were performed using Stata Statistical Software 
package® (StataCorp, College Station, TX) and a p-value <0.05 was deemed 
to be statistically significant.   
Results: 
A total of 879 individuals agreed to screening for chronic diseases with the 
majority (63.6%) of individuals being female. 
To better understand the progression of patients through this model, Figure 9 
provides an illustration of the flow of participants as they transitioned 
through the different phases.   
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Figure 9 – Flow Chart of Participant Progression through the Linkage 
and Retention Cascade 
M=male participants, F=female participants, RBS=random blood sugar, HTN=Hypertension, DM=diabetes 
mellitus, HTN Screen+ defined as SBP≥150mmHg or DBP≥90mmHg, DM Screen+ defined RBS≥7mmol/L 
(126 mg/dL) 
*15 individuals refused blood sugar screening 
†8 patients were HTN screen + and DM screen – on confirmation 
‡32 patients were screened for DM via point of care HbA1c testing when available with 9 becoming 
positive 
§ 8 patients didn’t have an elevated blood pressure upon returning to the groups and were excluded from 
further care assessments 
‖ 7 new female patients with known disease joined the groups over the course of the intervention 
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The initial screening results from Phase 1 found 23.1% were screen-positive 
for hypertension, 2.7% for diabetes and hypertension, and 5.3% for 
diabetes.  Upon completion of repeat testing for hypertension in Phase 2, 120 
(59.1%) screen-positive hypertension patients were confirmed with a second 
elevated blood pressure reading.  In total, 125 patients (14.2%) were found 
to be hypertensive when including individuals who were known to already 
have hypertension.  In the diabetes screen positive arms, the lack of 
availability of point of care HbA1c cartridges impeded the study from 
providing confirmatory diagnoses on the day of the screening for 38 patients.  
Despite being informed of the availability of free fasting blood sugar checks, 
only 2 patients returned for confirmation at a later date with only one of 
them being confirmed to have diabetes.  Of the 32 participants who received 
confirmation on the day of screening via point of care HbA1c, nine patients 
were confirmed to have diabetes with four patients having markedly elevated 
HbA1c’s above 13%.  While a true estimation of diabetes prevalence is not 
possible with the limited follow-up, 1.4% of the population were confirmed to 
have diabetes with 10 patients having diabetes with hypertension and 2 
patients with only diabetes. 
In the primary linkage analysis in Phase 3, 72.4% of the patients with 
disease linked to the initial group care education session with linkage 
frequencies of 74.2%, 100%, 100%, and 58.3% for patients with 
hypertension, diabetes and hypertension, diabetes alone, and previously 
known disease, respectively.  Women demonstrated a statistically 
significantly higher linkage frequency to care with 82.3% compared to 60.0% 
of men (OR=4.06, 95% CI [1.91-8.65], P<0.01) linking to the groups. 
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In the comparison of linkage frequencies with the historical control, there 
was a statistically significant, nearly three-fold higher likelihood of patients 
linking to care in the BIGPIC model compared to the traditional facility based 
care model (unadjusted OR=2.94, 95% CI [1.47 - 5.88], P<0.01 and 
adjusted OR=2.63, 95% CI [1.28 – 5.26], P<0.01).   
In the analysis of the care cascade after attendance at this initial group care 
meeting (Phase 3), 90 out of 108 (83.3%) patients joined microfinance 
groups and began to receive monthly portable care (Phase 4).  Of those 90 
patients from Phase 4, 76 (84.4%) remained within the care model 
throughout the 9 months of group care (Phase 5). In analyzing the retention 
of the patients who initially linked to care (Phase 3) and then followed up 
with care over the remaining 9 months of the evaluation (Phase 5), we found 
76 out of 108 participants (70.3%) remained in care throughout the 
intervention.  
The analysis of the blood pressure data for the patients who were retained 
throughout the intervention revealed a statistically significant decline at 3 
months from enrollment which persisted throughout the remaining period of 
evaluation for the intervention.  After 12 months of enrollment (9 months of 
group care), patients demonstrated a statistically significant mean decline of 
21mmHg in SBP (95% CI [13.9 to 28.4], P<0.01) and a statistically 
significant mean decline of 5mmHg drop in DBP (95% CI [1.4 to 7.6], 
P<0.01) as seen in Figure 10 and Table 5. 
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Figure 10 - Blood Pressure Trends Throughout the Care Cascade 
*P<0.05 via two-sided paired t test compared to baseline screening result 
SBP=systolic blood pressure in mmHg 
DBP=diastolic blood pressure in mmHg 
Table 5 - Blood Pressure Trends throughout the Care Cascade 
Amongst People Attending the Initial Screening 
*paired t test comparing screening result to results at different time intervals 
SBP=systolic blood pressure 
DBP=diastolic blood pressure 
 Screening 3 Month 6 Month 9 Month 12 Month 
Number of 
available 
results at 
each 
interval  
-All 
-Women 
-Men 
 
 
 
 
 
76 
57 
19 
 
 
 
 
 
70 
55 
15 
 
 
 
 
 
68 
52 
16 
 
 
 
 
 
73 
57 
16 
 
 
 
 
 
67 
53 
14 
 Mean 
SBP 
mmHg 
(95% CI) 
Mean 
DBP 
mmHg 
(95% 
CI) 
Mean 
SBP 
mmHg 
(95% 
CI) 
Mean 
DBP 
mmHg 
(95% 
CI) 
Mean 
SBP 
mmHg 
(95% 
CI) 
Mean 
DBP 
mmHg 
(95% 
CI) 
Mean 
SBP 
mmHg 
(95% 
CI) 
Mean 
DBP 
mmHg 
(95% CI) 
Mean 
SBP 
mmHg 
(95% 
CI) 
Mean 
DBP 
mmHg 
(95% 
CI) 
All 163 
(158-169) 
94 
(91-97) 
157 
(152-
162) 
92 
(89-95) 
152 
(147-
157) 
89 
(87-91) 
144 
(139-
149) 
93 
(90-95) 
140 
(135-
145) 
88 
(85-91) 
p-value*   0.04 0.25 <0.01 0.04 <0.01 0.64 <0.01 <0.01 
Women  165 
(160-171) 
95 
(92-98) 
157 
(151-
163) 
94 
(90-97) 
151 
(146-
157) 
90 
(87-92) 
143 
(138-
148) 
93 
(90-96) 
140 
(135-
145) 
85 
(85-92) 
Men  157 
(145-169) 
90 
(86-94) 
157 
(147-
167) 
86 
(82-89) 
152 
(140-
163) 
87 
(82-91) 
146 
(135-
158) 
91 
(85-96) 
139 
(130-
148) 
84 
(77-91) 
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Over the course of the year, the microfinance activities of the groups resulted 
in a total accumulated savings of $6,616.85 with dividend interest payments 
totaling $3,120.40 (47.2%) which was all paid out at the end of the year 
amongst the 167 participants from the community with and without chronic 
disease.  
A total of 32 patients were awarded for achieving individual targets with 4 
patients achieving a score of 100% and 28 patients achieving a score 
between 80 and 100%.  The top three groups were also awarded and 
received the financial payment during their microfinance activities. 
Summary and significance of the publication 
As LMICs continue to face an overwhelming burden of non-communicable 
diseases, integrated approaches like the BIGPIC model must be scaled up 
and investigated.  By demonstrating a much higher linkage frequency and 
superior reductions in blood pressure than traditional care delivery models 
relying on stationary facilities, this initiative has the potential to offer 
promising strategies that may alter the current reality that patients with 
chronic diseases in LMICs face.  The BIGPIC model represents a much 
needed departure from the donor dependent, facility-based models that are 
typically utilized with limited success in rural SSA settings.  With the inclusion 
of long term, patient-driven financing strategies, the BIGPIC model of care 
represents a program that could potentially be adapted to rural settings 
found throughout LMICs.  Efforts to broadly scale this model up are currently 
underway and there is a focused effort on determining which components of 
this model are responsible for the improvements in care.  This study, 
however, had several limitations which limit the external validity of the 
findings.  The study used a single arm study design which relied on 
convenience sampling within a health program (i.e. AMPATH) which has a 
department with extensive experience in providing microfinance and 
agricultural services.  The use of convenience sampling also carries several 
limitations as it is possible this analysis included individuals who were more 
likely to seek out care and may not accurately represent the entire 
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community.  However, to combat some of these limitations we are currently 
conducting a National Institutes of Health funded randomized controlled trial 
to evaluate the components of the model which are responsible for the 
pronounced improvement experienced by patients. 
Other publications  
Publications 6 & 7 Which approach to training should be used? (26, 
56) 
Most of the emphasis towards addressing the training needs in LMICs 
continues to focus primarily on increasing the quantity of providers available 
to deliver healthcare services with minimal consideration for the quality of 
trainees upon completion.  Through the publication of our novel approaches 
to training, I have been invited to author two editorials/reviews on best 
approaches for training in LMICs.  In publication 6, we describe how the 
current approaches to development need to be altered. The prevailing model 
for international development frequently includes boluses of reactive funding, 
external technical assistance, and often uncoordinated training efforts as 
brokered by aid organizations such as the Global Fund, the World Bank, and 
USAID(57).  The effects of this treatment are rapid with benefits quickly 
disappearing upon removal of donor support.  In contrast, an initial 
investment followed by smaller ever decreasing investments is much more 
likely to achieve long term benefits that create a responsive, proactive 
healthcare system rather than a reactive ineffective healthcare system that 
breaks in the face of every new crisis as seen with the recent Ebola epidemic 
in West Africa(56). 
We have also published an invited review of the different levels of our 
pharmacy training program to describe our approach to developing the next 
generation of global health leaders from Kenya and North America(26).  
Through our activities we have trained over 300 North America and Kenya 
pharmacy students at different stages in their education.  We have also 
expanded our program to incorporate training for medical students, medical 
residents, clinical officers, and peers to provide community-based support. 
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Publication 8 – What does Rural Diabetes Care look like?(58) 
As the many stakeholders involved in building care infrastructure in SSA 
continue to try to address the burden of diabetes, the many differences 
between the presentation of diabetes in urban and rural areas must be 
considered before applying suboptimal solutions.   
In order to highlight these unique differences, we published an invited article 
in Lancet Diabetes and Endocrinology to describe the characteristics of 
diabetes patients in rural Kenya.  Our comprehensive efforts in Western 
Kenya have helped address the current lack of data from rural settings by 
assessing care from all angles.  Our article highlighted the lower levels of 
health literacy, lower body weight / body mass index, long distances traveled 
to reach health facilities and the many costs patients have to pay when 
trying to access care in government facilities.  In addition to describing 
barriers, our evaluation of this clinic also found that this rural diabetes 
populations had high levels of care taker support within the community to 
help them address their diabetes related care needs.   
This paper has helped highlight the many unique characteristics that must be 
considered when delivering care to rural populations and has helped promote 
the need to treat patients with diabetes in rural SSA as a distinct condition 
with unique attributes requiring contextualized approaches(59).   
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LMIC  Low- and middle- income country 
NCD  Non-communicable disease 
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HTN  hypertension 
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HIC  High-income country 
PUCOP Purdue University College of Pharmacy 
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